LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research

News (ZH) - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies

LGC publishes ESG report for 2021-22

News (ZH) - This is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally.

Infectious disease researchers publish routes to ensure lessons are learned from COVD-19 when using PCR for monkeypox diagnosis

News (ZH) - The paper, titled “Monkeypox: another test for PCR”, focuses on how to ensure the PCR diagnosis tests being deployed for monkeypox will be most accurate and that lessons learned on PCR testing from the COVID-19 pandemic are applied to the current epidemic.

LGC Clinical Diagnostics extend collaboration with Stanford Medicine supporting global genetic and metabolomic diagnostic testing

News (ZH) - The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.

LGC launches free app-based cannabis testing training to support cannabis testing laboratories in their learning

News (ZH) - Easy-to-use app-based microlearning provides training in a range of cannabis-related topics

LGC to distribute InBio’s food allergen reference materials and immunoassays

News (ZH) - Expands LGC’s offering to more than 180 allergen reference materials for a range of applications including method development and method verification

LGC Board change

News (ZH) - Update

National agrifood partnership launched at Queen’s University Belfast

News (ZH) - We're pleased to launch the Centre for Excellence in Agriculture and Food Integrity, a strategic partnership to enhance and future-proof the UK agrifood industry through the development and application of innovative scientific-measurement solutions and digital technologies for greater assurance of the sustainability, reliability, safety and productivity of inherent supply chains.

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

News (ZH) - DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK

LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA

News (ZH) - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing